House Bill No. 1196, introduced by Representative Freeman, amends R.S. 22:1029(B) to enhance health insurance coverage for colorectal cancer screening colonoscopies and associated preventive services. The bill defines "routine colorectal cancer screening" in accordance with the latest recommendations from the American Cancer Society and the National Comprehensive Cancer Network, while explicitly excluding services deemed experimental or investigational. Notably, the bill classifies any colonoscopy performed for colorectal cancer screening as a screening service, regardless of whether any tissue is excised during the procedure. Additionally, it stipulates that any subsequent colonoscopy recommended by a healthcare provider following a routine screening will also be considered a routine colorectal cancer screening if it aligns with the established recommendations.

The proposed law aims to ensure comprehensive coverage for colorectal cancer screenings, thereby promoting early detection and prevention of the disease. The amendments adopted by the House clarify that coverage applies only when screenings are conducted in accordance with the specified clinical recommendations, and they include technical changes to improve the bill's clarity and effectiveness. Overall, this legislation seeks to improve access to essential preventive health services for individuals at risk of colorectal cancer.

Statutes affected:
HB1196 Original: 22:1029(B)
HB1196 Engrossed: 22:1029(B)
HB1196 Reengrossed: 22:1029(B)